Results for tag: "Personalized Cancer Vaccine"

The Personalized Cancer Vaccine market is a subset of the Genomics market, focused on the development of vaccines tailored to an individual's genetic makeup. This approach to cancer treatment is based on the idea that each person's cancer is unique, and that a vaccine tailored to their specific genetic profile can be more effective than a generic vaccine. The personalized cancer vaccine market is driven by advances in genomics technology, which allow for the rapid sequencing of an individual's genome and the development of a vaccine tailored to their specific genetic profile. The personalized cancer vaccine market is expected to grow in the coming years, as more research is conducted and more personalized vaccines are developed. Companies in the market include Adaptive Biotechnologies, Immunovant, and Oncolytics Biotech. Show Less Read more